Sunshine Biopharma Inc (SBFM)

0.4499 +0.10 (+28.58%) USD  |  NASDAQ  |  Jun 25, 16:00
0.4285 -0.02 (-4.76%) After-Hours: 20:00
More

Sunshine Biopharma Research and Development Expense (TTM): 1.645M for March 31, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2011. Upgrade now.
Date Value
March 31, 2024 1.645M
December 31, 2023 1.856M
September 30, 2023 1.081M
June 30, 2023 1.206M
March 31, 2023 0.8831M
December 31, 2022 0.8119M
September 30, 2022 0.8613M
June 30, 2022 0.7213M
March 31, 2022 0.8671M
December 31, 2021 0.6722M
September 30, 2021 0.5827M
June 30, 2021 0.3603M
March 31, 2021 0.1685M
December 31, 2020 0.0017M
September 30, 2020 0.00
June 30, 2020 0.0152M
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
Date Value
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014 0.423M
September 30, 2014 0.533M
June 30, 2014 0.533M
March 31, 2014 0.21M
December 31, 2013 0.1374M
September 30, 2013 0.0234M
June 30, 2013 0.0234M
March 31, 2013 0.0252M
December 31, 2012 0.0018M
September 30, 2012 0.1268M
June 30, 2012 0.1268M
March 31, 2012 0.125M
December 31, 2011 0.1427M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

--
Minimum
Sep 2020
1.856M
Maximum
Dec 2023
0.7333M
Average
0.7666M
Median

Research and Development Expense (TTM) Benchmarks

Lexaria Bioscience Corp 2.961M
Acasti Pharma Inc 4.683M
Aurinia Pharmaceuticals Inc 49.64M
Edesa Biotech Inc 3.860M
Xenon Pharmaceuticals Inc 172.25M